{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:16:54Z","timestamp":1792153014110,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.maturitas.2015.08.007","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T12:36:20Z","timestamp":1440074180000},"page":"402-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis"],"prefix":"10.1016","volume":"82","author":[{"given":"Sonia","family":"Morales-Santana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"D\u00edez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Olmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Nogu\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"D\u00edaz-Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"P\u00e9rez-Castrill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"P\u00e9rez-Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Torrijos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Jodar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Del","family":"Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Caeiro-Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Reyes-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Garc\u00eda-Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Gonz\u00e1lez-Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Mu\u00f1oz-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2015.08.007_bib0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis","volume":"11","author":"Garnero","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ecl.2012.04.006","article-title":"Pathophysiology of osteoporosis: new mechanistic insights","volume":"41","author":"Armas","year":"2012","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrrheum.2011.130","article-title":"New targets for intervention in the treatment of postmenopausal osteoporosis","volume":"7","author":"Lewiecki","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0020","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/j.1742-1241.2009.02206.x","article-title":"Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases","volume":"63","author":"Boonen","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0025","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00198-008-0659-2","article-title":"Inadequate responders to osteoporosis treatment: proposal for an operational definition","volume":"19","author":"Diez-Perez","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0030","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00198-012-2093-8","article-title":"Treatment failure in osteoporosis","volume":"23","author":"Diez-Perez","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0035","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/jbmr.1681","article-title":"Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab","volume":"27","author":"Gatti","year":"2012","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0040","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/en.2007-0270","article-title":"Targeting the Wnt\/beta-catenin pathway to regulate bone formation in the adult skeleton","volume":"148","author":"Baron","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2015.08.007_bib0045","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/jbmr.479","article-title":"Determinants of serum sclerostin in healthy pre- and postmenopausal women","volume":"26","author":"Ardawi","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0050","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"van Bezooijen","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0055","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0060","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","article-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor","volume":"280","author":"Semenov","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","article-title":"current knowledge and future perspectives","volume":"87","author":"Moester","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0070","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Res."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0075","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1086\/301721","article-title":"Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21","volume":"62","author":"Van Hul","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0085","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.090730","article-title":"Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice","volume":"25","author":"Kramer","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0090","unstructured":"US National Library of Medicine. ClinicalTrials.gov 2013; [online], http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01575834."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0095","unstructured":"US National Library of Medicine. ClinicalTrials.gov 2013; [online], http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01631214?term=NCT01631214&rank=1."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0100","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0105","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/jc.2009-2283","article-title":"Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women","volume":"95","author":"Mirza","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jbmr.128","article-title":"Regulation of circulating sclerostin levels by sex steroids in women and in men","volume":"26","author":"Modder","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0115","article-title":"Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women","author":"Chung","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0120","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bone.2009.03.676","article-title":"The-9247 T\/C polymorphism in the SOST upstream regulatory region that potentially affects C\/EBPalpha and FOXA1 binding is associated with osteoporosis","volume":"45","author":"Huang","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2015.08.007_bib0125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jbmr.1496","article-title":"Risk factors for prediction of inadequate response to antiresorptives","volume":"27","author":"Diez-Perez","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med. Care"},{"key":"10.1016\/j.maturitas.2015.08.007_bib0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00223-003-0158-6","article-title":"Discriminative capacity of calcaneal quantitative ultrasound and of osteoporosis and fracture risk factors in postmenopausal women with osteoporotic fractures","volume":"74","author":"Hernandez","year":"2004","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0140","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/jbmr.1718","article-title":"High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Exence for Osteoporosis Research Study","volume":"27","author":"Ardawi","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0145","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2011-3419","article-title":"Serum sclerostin and risk of hip fracture in older Caucasian women","volume":"97","author":"Arasu","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00198-012-1978-x","article-title":"Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study","volume":"24","author":"Garnero","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0155","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bone.2011.11.028","article-title":"Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin","volume":"50","author":"Gatti","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2015.08.007_bib0160","first-page":"263","article-title":"Sclerostin: a novel target for intervention in the treatment of osteoporosis","volume":"12","author":"Lewiecki","year":"2011","journal-title":"Discov. Med."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00198-004-1674-6","article-title":"Prediction of incident osteoporotic fractures in elderly women using the free estradiol index","volume":"16","author":"Devine","year":"2005","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199809103391104","article-title":"Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group","volume":"339","author":"Cummings","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00223-012-9611-8","article-title":"Endogenous estradiol and the risk of incident fracture in postmenopausal women: the OPUS study","volume":"91","author":"Finigan","year":"2012","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0180","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1359\/jbmr.2000.15.9.1835","article-title":"Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study","volume":"15","author":"Chapurlat","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0185","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00198-010-1525-6","article-title":"Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women-the six-month effect of risedronate and teriparatide","volume":"23","author":"Polyzos","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men","volume":"26","author":"Modder","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/humupd\/6.3.225","article-title":"Steroid hormone receptors: an update","volume":"6","author":"Beato","year":"2000","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.maturitas.2015.08.007_bib0200","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/er.2011-1050","article-title":"Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses","volume":"33","author":"Vandenberg","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0205","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2013.05.010","article-title":"The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women","volume":"56","author":"Hampson","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2015.08.007_bib0210","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/jbmr.1929","article-title":"Sclerostin and bone strength in women in their 10th decade of life","volume":"28","author":"Thorson","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0215","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/jbmr.1888","article-title":"Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study","volume":"28","author":"Szulc","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0220","article-title":"Sclerostin levels during growth in children","author":"Kirmani","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.maturitas.2015.08.007_bib0225","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1210\/jc.2013-2106","article-title":"Circulating sclerostin levels and markers of bone turnover in Chinese\u2013American and white women","volume":"98","author":"Costa","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512215300426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512215300426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:04:52Z","timestamp":1759914292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512215300426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0378512215300426"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2015.08.007","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2015.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}